Rare diseases
Investigational molecules
Locations
Back to Spain690 clinical trials in Santiago De Compostela, Spain across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)Long‑Term Follow‑Up Study of Belzupacap Sarotalocan in Patients with Early Choroidal Melanoma
SpainImmune response and safety of investigational MMRV vaccine (GSKVX000000025896) drug combination compared with standard MMRV vaccine in healthy children 15 months to 6 years
SpainEfficacy and safety of efgartigimod alfa in adults with Sjögren’s disease‑associated sensorimotor or sensory polyneuropathy: a phase 2 randomized placebo‑controlled study
SpainEfficacy and Safety of Intranasal Cenegermin in Adults with Non‑Arteritic Anterior Ischemic Optic Neuropathy (NAION)
SpainFeasibility of Sequential Radium Ra-223 Dichloride After Triplet Therapy in High‑Volume Metastatic Hormone‑Sensitive Prostate Cancer Patients (Phase II)
SpainEvaluating the efficacy and safety of CRD-4730 in patients with heart failure with reduced ejection fraction
SpainStudy of dupilumab added to standard care in adults hospitalized for COPD exacerbation to reduce readmissions, emergency visits, and death
SpainColchicine for Reducing Dependency and Vascular Events in Patients After Acute Intracerebral Hemorrhage
SpainA Phase 3 Study of Delgocitinib Cream to Evaluate Efficacy and Safety in Adult Women with Lichen Sclerosus
SpainLong‑Term Safety and Tolerability of Treprostinil Palmitil Inhalation Powder in Patients with Pulmonary Hypertension Associated with Interstitial Lung Disease
SpainLong‑term Safety and Tolerability of Admilparant in Adults with Idiopathic or Progressive Pulmonary Fibrosis
SpainAngiotensin II in Children and Adolescents With Refractory Hypotension in Distributive Shock
SpainThe busiest research cities in the country
What the registry says about research in the country
Innovative studies focusing on respiratory viral infections, including trials for RSV, influenza, and COVID-19 vaccines. Research aims to enhance protection in vulnerable populations, particularly adults over 60.
Multiple trials evaluating both single and combination vaccine approaches for respiratory diseases.
Research targeting cardiovascular health and prevention, with emphasis on innovative treatments for stroke and heart failure. Studies include both therapeutic interventions and preventive measures.
Focus on developing new therapeutic approaches for better patient outcomes.
Advanced clinical investigations in dermatological conditions, particularly focusing on moderate to severe cases of psoriasis and atopic dermatitis.
Trials evaluating novel therapeutic agents for chronic skin conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
